-
41
-
42
-
43
-
44
-
45
-
46
-
47
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
Published 2025-02-01Get full text
Article -
48
-
49
-
50
HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
Published 2020-01-01Get full text
Article -
51
-
52
-
53
Epidemiology, mechanisms, and clinical impact of bacterial heteroresistance
Published 2025-01-01Get full text
Article -
54
-
55
Advancing treatment choices: CDK4/6 inhibitor switching in HR+/HER2- metastatic breast cancer
Published 2025-02-01Get full text
Article -
56
Discovery of Novel Nav1.7-Selective Inhibitors with the 1H-Indole-3-Propionamide Scaffold for Effective Pain Relief
Published 2025-01-01“…Pharmacokinetic studies indicate that WN2-R has high bioavailability (F = 20.29%), highlighting its considerable potential for drug development. Our study establishes WN2-R as a novel Nav1.7-selective inhibitor with a unique structural scaffold, offering a promising candidate for the next generation of analgesic drugs.…”
Get full text
Article -
57
-
58
Transcriptome profiling of aged-mice ovaries administered with individual ingredients of Samul-tang
Published 2025-01-01Get full text
Article -
59
Drug-target binding affinity prediction based on power graph and word2vec
Published 2025-01-01“…Abstract Background Drug and protein targets affect the physiological functions and metabolic effects of the body through bonding reactions, and accurate prediction of drug-protein target interactions is crucial for drug development. In order to shorten the drug development cycle and reduce costs, machine learning methods are gradually playing an important role in the field of drug-target interactions. …”
Get full text
Article -
60
CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions
Published 2025-01-01Get full text
Article